P1.01-133 Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC

Authors :: Laureen S. Ojalvo
C. Martin
Edward B. Garon
Fabrice Barlesi
A. Koenig
Everett E. Vokes
Tony Mok
Isabelle Dussault
E. Felip
Luis Paz-Ares
M-J. Ahn
Source :: Journal of Thoracic Oncology. 14:S415
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
biology
business.industry
Pembrolizumab
Open label study
Internal medicine
PD-L1
biology.protein
Medicine
In patient
business

Tools